1 code implementation • Cell Research 2022 • Hantao Lou, Jian-Qing Zheng, Xiaohang Leo Fang, Zhu Liang, Meihan Zhang, Yu Chen, Chunmei Wang, Xuetao Cao
The COVID-19 pandemic has been ongoing for nearly two and half years, and new variants of concern (VOCs) of SARS-CoV-2 continue to emerge, which urges the development of broadly neutralizing antibodies.